StonvexLoading…
StonvexStonvexStonvexCore line items from BLFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $96.21M | $74.65M | $68.02M | $76.24M |
Operating Income | $-16.60M | $-4.48M | $-17.20M | $-5.92M |
Net Income | $-4.59M | $-20.18M | $-68.00M | $-139.81M |
EPS (Diluted) | $-0.10 | $-0.44 | $-1.55 | $-3.25 |
Total Assets | $405.88M | $399.49M | $412.71M | $450.23M |
Total Liabilities | $34.00M | $50.58M | $75.05M | $86.04M |
Cash & Equivalents | $33.04M | $91.54M | $27.90M | $19.44M |
Free Cash Flow OCF − CapEx | $10.64M | $5.20M | $-18.88M | $-18.87M |
Shares Outstanding | 48.20M | 46.91M | 45.17M | 42.83M |